CEL-SCI (CVM)

Search documents
CEL-SCI (CVM) - 2021 Q2 - Quarterly Report
2021-05-16 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to ______________. Commission File Number 001-11889 | --- | --- | --- | |----------------------------------------------|-------------------- ...
CEL-SCI (CVM) - 2021 Q1 - Quarterly Report
2021-02-11 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to ______________. Commission File Number 001-11889 | --- | --- | --- | |-----------------------------------------------------------|---- ...
CEL-SCI (CVM) - 2020 Q4 - Annual Report
2020-12-29 22:01
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to __________. Commission file number 001-11889 | --- | --- | --- | |-------------------------------------------------------------------------|---------------------- ...
CEL-SCI (CVM) - 2020 Q3 - Quarterly Report
2020-08-10 21:25
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Trading Symbol(s)Name of Each Exchange on Which Registered Common Stock CVM NYSE American Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Smaller reporting company ☒ Emerging growth company ☐ Class of Stock No. Shares Outstanding Date Common 38,624,084 August 5, 2020 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly ...
CEL-SCI (CVM) - 2020 Q2 - Quarterly Report
2020-05-08 21:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Class of Stock No. Shares Outstanding Date Common 37,633,894 May 5, 2020 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to ______________. Commission File Number 001-11889 CEL-SCI CORPORA ...
CEL-SCI (CVM) Investor Presentation - Slideshow
2020-02-11 18:19
| --- | --- | --- | --- | |------------------------|-------------------------------------------|------------------------------------------------------------------------------------|------------------------| | | | | | | | | | | | | | | | | Corporate Presentation | | | | | January 21, 2020 | | | | | CEL-SCI Corporation | Geert Kersten Chief Executive Officer | 8229 Boone Boulevard, Suite 802 Vienna, VA 22182, USA - Phone: (703) 506-9460 | NYSE American: CVM | Forward Looking Statements This presentations cont ...
CEL-SCI (CVM) - 2020 Q1 - Quarterly Report
2020-02-07 23:01
FORM 10-Q Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock CVM NYSE American UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to ______________. Commiss ...
CEL-SCI (CVM) - 2019 Q4 - Annual Report
2019-12-16 21:20
FORM 10-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) (X) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2019. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to __________. Commission file number 1-11889 CEL-SCI CORPORATION (Exact name of registrant as specified in its charter) COLORADO 84-0916344 (State or other juri ...
CEL-SCI Corporation (CVM) Investor Presentation - Slideshow
2019-09-17 06:00
| --- | --- | --- | --- | |--------------------------|-------------------------------------------|--------------------------------------------------------------------------------------|------------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation | | | | | September 10, 2019 | | | | | CEL-SCI Corporation | Geert Kersten Chief Executive Officer | 8229 Boone Boulevard, Suite 802 Vienna, VA 22182, USA - Phone: (703) 506-9460 | NYSE American: CVM | Forward Looking Statemen ...
CEL-SCI (CVM) - 2019 Q3 - Quarterly Report
2019-08-14 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to ______________. Commission File Number 001-11889 CEL-SCI CORPORATION Colorado 84-0916344 State or other jurisdiction incorporation (IRS) E ...